• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

背景实质强化:这仅仅是雌激素对乳腺的无害作用吗?

Background parenchymal enhancement: is it just an innocent effect of estrogen on the breast?

作者信息

Arslan Gözde, Çelik Levent, Çubuk Rahmi, Çelik Levent, Atasoy Mehmet Mahir

机构信息

Department of Radiology, Maltepe University School of Medicine, İstanbul, Turkey.

出版信息

Diagn Interv Radiol. 2017 Nov-Dec;23(6):414-419. doi: 10.5152/dir.2017.17048.

DOI:10.5152/dir.2017.17048
PMID:29097344
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5669540/
Abstract

PURPOSE

We aimed to retrospectively analyze whether background parenchymal enhancement (BPE) on breast magnetic resonance imaging (MRI) correlates with menarche, menopause, reproductive period, menstrual cycle, gravidity-parity, family history of breast cancer, and the Breast Imaging-Reporting and Data System (BI-RADS) category of the patient.

METHODS

The study included 126 pre- and 78 postmenopausal women who underwent breast MRI in our institute between 2011 and 2016. Patients had filled a questionnaire form before the MRI. Two radiologists blinded to patient history graded the BPEs and the results were compared and analyzed.

RESULTS

The BPE was correlated with patient age and the day of menstrual cycle (P < 0.01 for both). No correlation was found with menarche age, menopause age, total number of reproductive years, and family history of breast cancer. In the moderate BPE group, only 1 out of 35 patients and in the marked BPE group only 1 out of 13 patients were postmenopausal and had BI-RADS scores of 4 and 5, respectively.

CONCLUSION

Increased symmetrical BPE is mainly due to current hormonal status in the premenopausal women. High-grade BPE, whether symmetrical or not, is rarely seen in postmenopausal women; hence, these patients should be further investigated or closely followed up.

摘要

目的

我们旨在回顾性分析乳腺磁共振成像(MRI)中的背景实质强化(BPE)是否与初潮、绝经、生育期、月经周期、妊娠次数、乳腺癌家族史以及患者的乳腺影像报告和数据系统(BI-RADS)分类相关。

方法

该研究纳入了2011年至2016年间在我院接受乳腺MRI检查的126例绝经前和78例绝经后女性。患者在MRI检查前填写了一份问卷。两名对患者病史不知情的放射科医生对BPE进行分级,并对结果进行比较和分析。

结果

BPE与患者年龄和月经周期天数相关(两者P均<0.01)。未发现与初潮年龄、绝经年龄、生育总年数和乳腺癌家族史相关。在中度BPE组中,35例患者中只有1例为绝经后患者,在显著BPE组中,13例患者中只有1例为绝经后患者,其BI-RADS评分分别为4和5。

结论

绝经前女性对称性BPE增加主要归因于当前的激素状态。绝经后女性很少见到高级别BPE,无论是否对称;因此,应对这些患者进行进一步检查或密切随访。

相似文献

1
Background parenchymal enhancement: is it just an innocent effect of estrogen on the breast?背景实质强化:这仅仅是雌激素对乳腺的无害作用吗?
Diagn Interv Radiol. 2017 Nov-Dec;23(6):414-419. doi: 10.5152/dir.2017.17048.
2
Gadoteridol-enhanced MRI of the breast: can contrast agent injection rate impact background parenchymal enhancement?钆特醇增强乳腺 MRI:对比剂注射速率是否会影响背景实质增强?
Acta Radiol. 2022 Sep;63(9):1173-1179. doi: 10.1177/02841851211034038. Epub 2021 Jul 29.
3
Association of breast cancer with MRI background parenchymal enhancement: the IMAGINE case-control study.乳腺癌与 MRI 背景实质增强的相关性:IMAGINE 病例对照研究。
Breast Cancer Res. 2020 Dec 7;22(1):138. doi: 10.1186/s13058-020-01375-7.
4
Background Parenchymal Enhancement on Contrast-Enhanced Spectral Mammography: Influence of Age, Breast Density, Menstruation Status, and Menstrual Cycle Timing.背景:对比增强光谱乳腺摄影中的实质增强:年龄、乳腺密度、月经状态和月经周期时间的影响。
Sci Rep. 2020 May 25;10(1):8608. doi: 10.1038/s41598-020-65526-8.
5
Analysis of background parenchymal echogenicity on breast ultrasound: Correlation with mammographic breast density and background parenchymal enhancement on magnetic resonance imaging.乳腺超声背景实质回声分析:与乳腺钼靶密度及磁共振成像背景实质强化的相关性
Medicine (Baltimore). 2017 Aug;96(33):e7850. doi: 10.1097/MD.0000000000007850.
6
Association of Clinical Factors and Degree of Early Background Parenchymal Enhancement on Contrast-Enhanced Mammography.临床因素与对比增强乳腺摄影中早期背景实质增强程度的相关性研究。
AJR Am J Roentgenol. 2023 Jul;221(1):45-55. doi: 10.2214/AJR.22.28769. Epub 2023 Jan 25.
7
Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast MRI.绝经状态对乳腺 MRI 背景实质强化和纤维腺体组织的影响。
Eur Radiol. 2012 Dec;22(12):2641-7. doi: 10.1007/s00330-012-2553-8. Epub 2012 Jul 4.
8
Does breast MRI background parenchymal enhancement indicate metabolic activity? Qualitative and 3D quantitative computer imaging analysis.乳腺 MRI 背景实质强化是否表示代谢活性?定性和 3D 定量计算机成像分析。
J Magn Reson Imaging. 2018 Mar;47(3):753-759. doi: 10.1002/jmri.25798. Epub 2017 Jun 24.
9
Factors Associated With Background Parenchymal Enhancement on Contrast-Enhanced Mammography.与对比增强乳腺摄影中背景实质增强相关的因素。
AJR Am J Roentgenol. 2021 Feb;216(2):340-348. doi: 10.2214/AJR.19.22353. Epub 2020 Dec 23.
10
Breast Background Parenchymal Enhancement on Screening Magnetic Resonance Imaging in Women Who Received Chest Radiotherapy for Childhood Hodgkin's Lymphoma.接受儿童霍奇金淋巴瘤胸部放疗的女性在乳腺磁共振成像筛查中的乳腺背景实质强化情况
Acad Radiol. 2016 Feb;23(2):168-75. doi: 10.1016/j.acra.2015.09.010. Epub 2015 Nov 3.

引用本文的文献

1
Misdiagnosis in breast imaging: a statement paper from European Society Breast Imaging (EUSOBI)-Part 2: Main causes of errors in breast imaging and recommendations from European Society of Breast Imaging to limit misdiagnosis.乳腺影像诊断中的误诊:欧洲乳腺影像学会(EUSOBI)的声明文件 - 第2部分:乳腺影像诊断错误的主要原因及欧洲乳腺影像学会为减少误诊提出的建议
Eur Radiol. 2025 May;35(5):2397-2411. doi: 10.1007/s00330-024-11133-4. Epub 2024 Nov 15.
2
High-background parenchymal enhancement in the contralateral breast is an imaging biomarker for favorable prognosis in patients with triple-negative breast cancer treated with chemotherapy.对侧乳腺实质高背景强化是接受化疗的三阴性乳腺癌患者预后良好的一种影像生物标志物。
Am J Transl Res. 2021 May 15;13(5):4422-4436. eCollection 2021.
3
Background Parenchymal Enhancement on Breast MRI as a Prognostic Surrogate: Correlation With Breast Cancer Oncotype Dx Score.背景:乳腺MRI实质强化作为一种预后替代指标:与乳腺癌Oncotype Dx评分的相关性
Front Oncol. 2021 Feb 4;10:595820. doi: 10.3389/fonc.2020.595820. eCollection 2020.
4
Breast cancer and background parenchymal enhancement at breast magnetic resonance imaging: a meta-analysis.乳腺癌与乳腺磁共振成像背景实质强化:一项荟萃分析。
BMC Med Imaging. 2021 Feb 19;21(1):32. doi: 10.1186/s12880-021-00566-8.
5
Comparison of Segmentation Methods in Assessing Background Parenchymal Enhancement as a Biomarker for Response to Neoadjuvant Therapy.评估背景实质强化作为新辅助治疗反应生物标志物的分割方法比较。
Tomography. 2020 Jun;6(2):101-110. doi: 10.18383/j.tom.2020.00009.
6
Harmonization of Quantitative Parenchymal Enhancement in T -Weighted Breast MRI.乳腺T加权磁共振成像中实质定量强化的标准化
J Magn Reson Imaging. 2020 Nov;52(5):1374-1382. doi: 10.1002/jmri.27244. Epub 2020 Jun 3.
7
Association between MRI background parenchymal enhancement and lymphovascular invasion and estrogen receptor status in invasive breast cancer.MRI 背景实质增强与浸润性乳腺癌的淋巴管血管侵犯及雌激素受体状态的相关性。
Br J Radiol. 2019 Nov;92(1103):20190417. doi: 10.1259/bjr.20190417. Epub 2019 Aug 9.
8
Tualang honey adjunct with anastrozole improve parenchyma enhancement of breast tissue in breast cancer patients: A randomized controlled trial.蜂糖辅助阿那曲唑改善乳腺癌患者乳腺组织实质强化:一项随机对照试验。
Integr Med Res. 2018 Dec;7(4):322-327. doi: 10.1016/j.imr.2018.07.002. Epub 2018 Jul 23.

本文引用的文献

1
Reply to "Breast MRI background parenchymal enhancement (BPE) correlates with the risk of breast cancer".对《乳腺磁共振成像背景实质强化(BPE)与乳腺癌风险相关》的回复
Magn Reson Imaging. 2016 Nov;34(9):1337-1338. doi: 10.1016/j.mri.2016.07.013. Epub 2016 Jul 27.
2
MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer.MRI背景实质强化与乳腺癌无关。
PLoS One. 2016 Jul 5;11(7):e0158573. doi: 10.1371/journal.pone.0158573. eCollection 2016.
3
Breast MRI background parenchymal enhancement (BPE) correlates with the risk of breast cancer.乳腺磁共振成像背景实质强化(BPE)与乳腺癌风险相关。
Magn Reson Imaging. 2016 Feb;34(2):173-6. doi: 10.1016/j.mri.2015.10.014. Epub 2015 Oct 24.
4
Quantitative assessment of background parenchymal enhancement in breast MRI predicts response to risk-reducing salpingo-oophorectomy: preliminary evaluation in a cohort of BRCA1/2 mutation carriers.乳腺MRI中背景实质强化的定量评估可预测降低风险的输卵管卵巢切除术的反应:BRCA1/2突变携带者队列的初步评估
Breast Cancer Res. 2015 May 19;17:67. doi: 10.1186/s13058-015-0577-0.
5
Are Qualitative Assessments of Background Parenchymal Enhancement, Amount of Fibroglandular Tissue on MR Images, and Mammographic Density Associated with Breast Cancer Risk?磁共振成像中背景实质强化、纤维腺体量的定性评估以及乳腺X线密度与乳腺癌风险相关吗?
Radiology. 2015 Aug;276(2):371-80. doi: 10.1148/radiol.2015142304. Epub 2015 May 12.
6
TLRs: linking inflammation and breast cancer.Toll样受体:连接炎症与乳腺癌
Cell Signal. 2014 Nov;26(11):2350-7. doi: 10.1016/j.cellsig.2014.07.035. Epub 2014 Aug 3.
7
Vascular measurements correlate with estrogen receptor status.血管测量结果与雌激素受体状态相关。
BMC Cancer. 2014 Apr 23;14:279. doi: 10.1186/1471-2407-14-279.
8
Background parenchymal enhancement at breast MR imaging: normal patterns, diagnostic challenges, and potential for false-positive and false-negative interpretation.背景实质增强在乳腺磁共振成像中的表现:正常模式、诊断挑战,以及假阳性和假阴性解读的潜在可能性。
Radiographics. 2014 Jan-Feb;34(1):234-47. doi: 10.1148/rg.341135034.
9
Effect of the menstrual cycle on background parenchymal enhancement in breast MR imaging.月经周期对乳腺磁共振成像背景实质增强的影响。
Magn Reson Med Sci. 2013 Mar 25;12(1):39-45. doi: 10.2463/mrms.2012-0022. Epub 2013 Mar 11.
10
Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies.月经初潮、绝经和乳腺癌风险:个体参与者荟萃分析,包括来自 117 项流行病学研究的 118964 名乳腺癌女性。
Lancet Oncol. 2012 Nov;13(11):1141-51. doi: 10.1016/S1470-2045(12)70425-4. Epub 2012 Oct 17.